US Patent 11155544 Heterocycle comprising tyrosine kinase inhibitors
Patent 11155544 was granted and assigned to Principia Biopharma Inc. on October, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11155544 Heterocycle comprising tyrosine kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
